| Stage | RBA | % of rev | TKO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $1.5B | 100.00% | TKO ×1.17 |
| Gross profit | $575M | 43.63% | $1.5B | 100.00% | TKO +56.4pp |
| Operating income | $225M | 17.07% | $430M | 27.78% | TKO +10.7pp |
| Pre-tax income | $186M | 14.12% | $362M | 23.37% | TKO +9.3pp |
| Net income | $144M | 10.90% | $304M | 19.65% | TKO +8.7pp |
| Stage | RBA | TKO | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $1.5B100.00% | TKO ×1.17 |
| Gross profit | 43.63%$575M | 100.00%$1.5B | TKO +56.4pp |
| Operating income | 17.07%$225M | 27.78%$430M | TKO +10.7pp |
| Pre-tax income | 14.12%$186M | 23.37%$362M | TKO +9.3pp |
| Net income |
| 10.90%$144M |
| 19.65%$304M |
| TKO +8.7pp |
No disclosed counterparties: RBA, TKO.